DoximityDOCS
DOCS
About: Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Employees: 830
0
Funds holding %
of 7,429 funds
0
Analysts bullish %
of 11 analysts
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
2% more capital invested
Capital invested by funds: $7.28B [Q1] → $7.46B (+$178M) [Q2]
2% more call options, than puts
Call options by funds: $85M | Put options by funds: $83.5M
5% less funds holding
Funds holding: 484 [Q1] → 462 (-22) [Q2]
5.13% less ownership
Funds ownership: 93.99% [Q1] → 88.86% (-5.13%) [Q2]
12% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 108
15% less repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 173
60% less funds holding in top 10
Funds holding in top 10: 5 [Q1] → 2 (-3) [Q2]
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$59
11%
downside
Avg. target
$68
2%
upside
High target
$80
20%
upside
11 analyst ratings
6 positive
55%
5 neutral
45%
0 negative
0%
Piper Sandler Jessica Tassan | 4%upside $69 | Overweight Maintained | 11 Aug 2025 |
Canaccord Genuity Richard Close | 11%downside $59 | Hold Maintained | 8 Aug 2025 |
Raymond James Brian Peterson | 13%upside $75 | Outperform Maintained | 8 Aug 2025 |
Wells Fargo Stan Berenshteyn | 2%downside $65 | Equal-Weight Maintained | 8 Aug 2025 |
Needham Ryan MacDonald | 13%upside $75 | Buy Maintained | 8 Aug 2025 |
Financial journalist opinion
Based on 13 articles about DOCS published over the past 30 days
Positive
Zacks Investment Research
2 weeks ago
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Positive
Benzinga
2 weeks ago
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.
Neutral
Seeking Alpha
2 weeks ago
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relations Conference Call Participants Allen Charles Lutz - BofA Securities, Research Division Brian Christopher Peterson - Raymond James & Associates, Inc., Research Division Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Division David Michael Larsen - BTIG, LLC, Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division Michael Aaron Cherny - Leerink Partners LLC, Research Division Ryan Michael MacDonald - Needham & Company, LLC, Research Division Ryan Scott Daniels - William Blair & Company L.L.C.
Neutral
The Motley Fool
2 weeks ago
Doximity (DOCS) Q1 Revenue Rises 15%
Doximity (DOCS) Q1 Revenue Rises 15%
Positive
Zacks Investment Research
2 weeks ago
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.28 per share a year ago.
Positive
CNBC
2 weeks ago
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said.
Neutral
Business Wire
2 weeks ago
Doximity Acquires Pathway, a Leader in AI Clinical Reference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across al.
Neutral
Business Wire
2 weeks ago
Doximity Announces Fiscal 2026 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. “We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products,” said Jeff Tangney, co-founder and CEO of Doximity. “Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save.
Positive
The Motley Fool
3 weeks ago
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the industries and sectors you gravitate toward, the amount of capital you have to invest, and your own personal risk tolerance.
Positive
Zacks Investment Research
3 weeks ago
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charts implemented using Lightweight Charts™